Expression of a Splice Variant of KAI1, a Tumor Metastasis Suppressor Gene, Influences Tumor Invasion and Progression

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7247-7255

  Lee, Ji Hee ^a   Seo, Young Woo ^b   Park, Sei Ryun ^a   Kim, Young Jin ^a   Kim, Kyung Keun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; BETA1 INTEGRIN; CD82 ANTIGEN; DNA; GENE PRODUCT; INTEGRIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL JUNCTION; CELL MOTILITY; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DELETION MUTANT; DISEASE MARKER; DNA DETERMINATION; EXON; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KAI1 GENE; LIVER; LUNG PARENCHYMA; METASTASIS; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR GROWTH; TUMOR METASTASIS SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE; WILD TYPE;

ADENOCARCINOMA; ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD; CADHERINS; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; GENES, TUMOR SUPPRESSOR; HUMANS; INTEGRIN ALPHA3BETA1; KANGAI-1 PROTEIN; MEMBRANE GLYCOPROTEINS; MICE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0242526105     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Dong, J. T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Wash. DC), 268: 884-886, 1995.
2. Angelisova, P., Hilgert, I., and Horejsi, V. Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics, 39: 249-256, 1994.
3. Wright, M. D., and Tomlinson, M. G. The ins and outs of the transmembrane 4 superfamily. Immunol. Today, 15: 588-594, 1994.
4. Maecker, H. T., Todd, S. C., and Levy, S. The tetraspanin superfamily: molecular facilitators. FASEB J., 11: 428-442, 1997.
5. Adachi, M., Taki, T., Ieki, Y., Huang, C. L., Higashiyama, M., and Miyake, M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res., 56: 1751-1755, 1996.
6. Hemler, M. E., Mannion, B. A., and Berditchevski, F. Association of TM4SF proteins with integrins: relevance to cancer. Biochim. Biophys. Acta, 1287: 67-71, 1996.
7. Berditchevski, F., Tolias, K. F., Wong, K., Carpenter, C. L., and Hemler, M. E. A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4-kinase. J. Biol. Chem., 272: 2595-2598, 1997.
8. Dong, J. T., Suzuki, H., Pin, S. S., Bova, G. S., Schalken, J. A., Isaacs, W. B., Barrett, J. C., and Isaacs, J. T. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res., 56: 4387-4390, 1996.
9. Guo, X., Friess, H., Graber, H. U., Kashiwagi, M., Zimmermann, A., Korc, M., and Buchler, M. W. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res., 56: 4876-4880, 1996.
10. Yang, X., Wei, L. L., Tang, C. K., and Lippman, M. E. KAI1 protein is down regulated during the progression of human breast cancer. Clin. Cancer Res., 6: 3424-3429, 2000.
11. Miyazaki, T., Kato, H., Shitara, Y., Yoshikawa, M., Tajima, K., Masuda, N., Shouji, H., Tsukada, K., Nakajima, T., and Kuwano, H. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer (Phila.), 89: 955-962, 2000.
12. Takaoka, A., Hinoda, Y., Sato, S., Itoh, F., Adachi, M., Hareyama, M., and Imai, K. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells. Jpn. J. Cancer Res., 89: 397-404, 1998.
13. Takaoka, A., Hinoda, Y., Satoh, S., Adachi, Y., Itoh, F., Adachi, M., and Imai, K. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene, 16: 1443-1453, 1998.
14. WAF1/CIP1-dependent manner: its potential utility in local gene therapy of tumor. Cell Growth Differ., 12: 243-254, 2001.
15. Bienstock, R. J., and Barrett, J. C. KAI1, a prostate metastasis suppressor: prediction of solvated structure and interactions with binding partners; integrins, cadherins, and cell-surface receptor proteins. Mol. Carcinog., 32: 139-153, 2001.
16. Birchmeier, W., and Behrens, J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta, 27: 11-26, 1994.
17. Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., and Derynck, R. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β I. J. Cell Biol., 118: 715-726, 1992.
18. 6 integrin is associated with malignant conversion in mouse skin tumorigenesis. Proc. Natl. Acad. Sci. USA, 92: 7041-7045, 1995.
19. 1 integrin in determining malignant properties of colon carcinoma cells. Cell Growth Differ., 8: 83-90, 1997.
20. Geng, L., Ali, S. A., Marshall, J. F., Mackay, C. L., Hart, I. R., Delcommence, M., Streuli, C. H., and Rees, R. C. Fibronectin is chemotactic for CT 26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization. Clin. Exp. Metastasis, 16: 683-691, 1998.
21. Straus, A. H., Carter, W. G., Wayner, E. A., and Hakomori, S. Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin). Exp. Cell Res., 183: 126-139, 1989.
22. Fearon, D. T. The, C. D.19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes. Curr. Opin. Immunol., 5: 341-348, 1993.
23. Lebel-Binay, S., Lagaudriere, C., Fradelizi, D., and Conjeaud, H. CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol., 155: 101-110, 1995.
24. Lebel-Binay, S., Lagaudriere, C., Fradelizi, D., and Conjeaud, H. CD82, tetra-span-transmembrane protein, is a regulated transducing molecule on U937 monocytic cell line. J. Leukocyte Biol., 57: 956-963, 1995.
25. Rubinstein, E., Le Naour, F., Billard, M., Prenant, M., and Boucheix, C. CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur. J. Immunol., 24: 3005-3013, 1994.
26. Seehafer, J. G., and Shaw, A. R. Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins. Biochem. Biophys. Res. Commun., 179: 401-406, 1991.
27. Clark, E. A., and Brugge, J. S. Integrins and signal transduction pathways: the road taken. Science (Wash. DC), 14: 233-239, 1995.
28. Miyamoto, S., Teramoto, H., Coso, O. A., Gutkind, J. S., Burbelo, P. D., Akiyama, S. K., and Yamada, K. M. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol., 131: 791-805, 1995,
29. Hynes, R. O. Targeted mutations in cell adhesion genes: what have we learned from them? Dev. Biol., 180: 402-412, 1996.
30. 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol., 129: 867-879, 1995.
31. Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., and Giancotti, F. G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell, 87: 733-743, 1996.
32. Keely, P. J., Westwick, J. K., Whitehead, I. P., Der, C. J., and Parise, L. V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature (Lond.), 390: 632-636, 1997,
33. Huttenlocher, A., Lakonishok, M., Kinder, M., Wu, S., Truong, T., Knudsen, K. A., and Horwitz, A. F. Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J. Cell Biol., 20: 515-526, 1998.
34. Gimond, C., van Der Flier, A., van Delft, S., Brakebusch, C., Kuikman, I., Collard, J. G., Fassler, R., and Sonnenberg, A. Induction of cell scattering by expression of β1 integrins in β1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. J. Cell Biol., 13: 1325-1340, 1999.
35. Huang, C. I., Kohno, N., Ogawa, E., Adachi, M., Taki, T., and Miyake, M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am. J. Pathol., 153: 973-983, 1998.
36. Yu, Y., Yang, J. L., Markovic, B., Jackson, P., Yardley, G., Barrett, J., and Russell, P. J. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin. Cancer Res., 3: 1045-1049, 1997.
37. Hinoda, Y., Adachi, Y., Takaoka, A., Mitsuuchi, H., Satoh, Y., Itoh, F., Kondoh, Y., and Imai, K. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer. Cancer Lett., 129: 229-234, 1998.
38. Phillips, K. K., White, A. E., Hicks, D. J., Welch, D. R., Barrett, J. C., Wei, L. L., and Weissman, B. E. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Mol. Carcinog., 21: 111-120, 1998.
39. Jackson, P., Kingsley, E. A., and Russell, P. J. Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines. Cancer Lett., 156: 9-17, 2000.